About FFEI
FFEI is a Healthcare company based in Hemel Hempstead (United Kingdom) founded in 1947, and was acquired by Xaar in July 2021. Digital imaging technology for diagnostics and scanning is provided. The company has 66 employees.
Company details
Founded in 1947 and based in Hemel Hempstead, United Kingdom, FFEI operates in the digital imaging sector. Proprietary technology is utilized for pathological cell scanning, producing 3D images with ultra-high resolution and micro mechanisms. OEM products are offered alongside ink-jet solutions for graphic arts applications. Services focus on diagnostics and imaging support across medical and creative fields.
- Headquarters Hemel Hempstead, United Kingdom
- Employees 66
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ffei.co.uk
- Social LinkedIn X
- Acquired by Xaar (Jul 2021)
Investors in FFEI
FFEI has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Xaar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Commercial inkjet printing heads are developed by Xaar. | 1990 | xaar.com | Cambridge, United Kingdom |
Investor details for FFEI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of FFEI
2 dated milestones of FFEI across 74 years, from founding to its latest funding, stage changes and deals.
- Founded FFEI is founded.
- Exit Acquired by Xaar.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as FFEI (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about FFEI
FFEI was founded in 1947.
FFEI is headquartered in Hemel Hempstead, United Kingdom.
FFEI has 66 employees.
Annual revenue of FFEI is $12.9K as on Mar 31, 2021.
Founded in 1947 and based in Hemel Hempstead, United Kingdom, FFEI operates in the digital imaging sector. Proprietary technology is utilized for pathological cell scanning, producing 3D images with ultra-high resolution and micro mechanisms. OEM products are offered alongside ink-jet solutions for graphic arts applications. Services focus on diagnostics and imaging support across medical and creative fields.
FFEI has 1 investor. Key investors include Xaar.
Yes. FFEI was acquired by Xaar in July 2021.